Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

OTTMUSG00000010432 Activators

LOC100041077 isoform X1, encoded by the gene Gm13102, represents a specific protein whose detailed functional characteristics and mechanisms of activation are not extensively documented in the scientific literature. However, a logical analysis based on general biochemical and cellular principles can provide insights into potential pathways for its activation. Proteins such as LOC100041077 isoform X1 are typically regulated and activated through various post-translational modifications, with phosphorylation being a common and critical mechanism. This process involves the addition of phosphate groups to the protein, catalyzed by enzymes known as kinases. The phosphorylation can alter the protein's structure and function, enabling it to interact with other molecules, alter its location within the cell, or change its enzymatic activity. Thus, the activation of LOC100041077 isoform X1 could feasibly occur through kinase-mediated pathways, which are often triggered by upstream signaling events, such as changes in intracellular second messenger levels (like cAMP and calcium) or activation of specific receptors on the cell surface.

The selected chemicals in the table influence these signaling pathways and cellular processes, potentially leading to the activation of LOC100041077 isoform X1. Compounds that elevate cAMP levels, such as Forskolin and Rolipram, lead to the activation of Protein Kinase A (PKA), which can phosphorylate a variety of substrates. Similarly, an increase in intracellular calcium levels, induced by agents like Ionomycin, can activate calmodulin-dependent kinases, which are also capable of modifying numerous proteins, including potentially LOC100041077 isoform X1. Furthermore, modulation of cGMP levels by chemicals like Sildenafil or Zaprinast activates Protein Kinase G (PKG), which could play a role in the phosphorylation and subsequent activation of LOC100041077 isoform X1. Given the complexity of cellular signaling networks, the exact mechanism by which these chemicals activate LOC100041077 isoform X1 may involve direct interactions with the protein or more indirect effects through modulation of related pathways or cellular environment. It's important to acknowledge that while these hypotheses are grounded in established biochemical principles, experimental validation is essential to confirm the specific role and mechanism of these chemicals in the activation of LOC100041077 isoform X1. This approach is consistent with the scientific method, where hypotheses based on current knowledge guide experimental investigations to uncover new insights into biological processes and protein functions.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA activates Protein Kinase C (PKC), which can lead to the activation of LOC100041077 isoform X1. PKC activation results in phosphorylation of various proteins, potentially including direct phosphorylation of LOC100041077 isoform X1 or altering the cellular environment to favor its activation.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin raises intracellular calcium levels, which activate calmodulin-dependent kinases. These kinases can phosphorylate and activate several proteins. This increase in calcium levels and subsequent kinase activation can lead to the activation of LOC100041077 isoform X1.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Rolipram inhibits phosphodiesterase 4, leading to increased cAMP levels and activation of PKA. PKA may phosphorylate and activate LOC100041077 isoform X1, enhancing its functional activity within the cellular context.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG modulates various signaling pathways, potentially activating LOC100041077 isoform X1 by modulating kinase activities or cellular signaling cascades that lead to the phosphorylation and activation of the protein.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

db-cAMP, a cAMP analog, activates PKA. PKA can phosphorylate and activate LOC100041077 isoform X1, leading to its functional activation through conformational changes or interaction with other proteins.

8-CPT-cAMP

93882-12-3sc-201569
sc-201569A
20 mg
100 mg
$87.00
$316.00
19
(1)

8-CPT-cAMP activates the cAMP-dependent PKA pathway. PKA activation could lead to the phosphorylation and activation of LOC100041077 isoform X1, enhancing its functional activity within cellular signaling pathways.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

Anisomycin activates JNK (c-Jun N-terminal Kinase) signaling pathways. Activation of JNK can lead to the activation of several downstream proteins, potentially including LOC100041077 isoform X1, by altering their phosphorylation state.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Staurosporine, at low concentrations, can act as an activator of kinase pathways. It may indirectly activate LOC100041077 isoform X1 through its effects on kinase pathways, possibly influencing the phosphorylation state or interaction of the protein with other cellular proteins.

Zaprinast (M&B 22948)

37762-06-4sc-201206
sc-201206A
25 mg
100 mg
$105.00
$250.00
8
(2)

Zaprinast inhibits phosphodiesterases, particularly PDE5, leading to increased cGMP levels. Elevated cGMP can activate PKG, potentially leading to the phosphorylation and activation of LOC100041077 isoform X1.